BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 28893175)

  • 21. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.
    Kim JH; Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC
    Am J Cardiol; 2014 Dec; 114(12):1830-5. PubMed ID: 25438909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous Coronary Intervention Does Not Lower Cardiovascular Outcomes in Patients with Chronic Kidney Disease.
    Chernin G; Chen S; Ozan O; Liu M; Haberman D; Perlman G; Ben-Yehuda O; Jonas M
    Am J Nephrol; 2019; 50(6):465-472. PubMed ID: 31655801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled Trials.
    Baber U; Giustino G; Sartori S; Aquino M; Stefanini GG; Steg PG; Windecker S; Leon MB; Wijns W; Serruys PW; Valgimigli M; Stone GW; Dangas GD; Morice MC; Camenzind E; Weisz G; Smits PC; Kandzari D; Von Birgelen C; Mastoris I; Galatius S; Jeger RV; Kimura T; Mikhail GW; Itchhaporia D; Mehta L; Ortega R; Kim HS; Kastrati A; Chieffo A; Mehran R
    JACC Cardiovasc Interv; 2016 Jan; 9(1):28-38. PubMed ID: 26762908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients.
    Tabata N; Hokimoto S; Akasaka T; Arima Y; Sakamoto K; Yamamoto E; Tsujita K; Izumiya Y; Yamamuro M; Kojima S; Kaikita K; Ogawa H
    Heart Vessels; 2016 Jul; 31(7):1038-44. PubMed ID: 26164597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The risk trajectory of different cardiovascular morbidities associated with chronic kidney disease among patients with newly diagnosed diabetes mellitus: a propensity score-matched cohort analysis.
    Chao CT; Lee SY; Wang J; Chien KL; Hung KY
    Cardiovasc Diabetol; 2021 Apr; 20(1):86. PubMed ID: 33894776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of chronic total occlusion and chronic kidney disease in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
    Bataille Y; Plourde G; Machaalany J; Abdelaal E; Déry JP; Larose E; Déry U; Noël B; Barbeau G; Roy L; Costerousse O; Bertrand OF
    Am J Cardiol; 2013 Jul; 112(2):194-9. PubMed ID: 23601580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Chronic Kidney Disease and Anemia on Outcomes After Percutaneous Coronary Revascularization.
    Cilia L; Sharbaugh M; Marroquin OC; Toma C; Smith C; Thoma F; Lee J; Mulukutla SR
    Am J Cardiol; 2019 Sep; 124(6):851-856. PubMed ID: 31375241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impacts of chronic kidney disease and diabetes on cardiovascular mortality in a general Japanese population: A 20-year follow-up of the NIPPON DATA90 study.
    Hirata A; Okamura T; Sugiyama D; Kuwabara K; Kadota A; Fujiyoshi A; Miura K; Okuda N; Ohkubo T; Okayama A; Ueshima H;
    Eur J Prev Cardiol; 2017 Mar; 24(5):505-513. PubMed ID: 27856810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial.
    Dangas GD; Farkouh ME; Sleeper LA; Yang M; Schoos MM; Macaya C; Abizaid A; Buller CE; Devlin G; Rodriguez AE; Lansky AJ; Siami FS; Domanski M; Fuster V;
    J Am Coll Cardiol; 2014 Sep; 64(12):1189-97. PubMed ID: 25236509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease.
    Roberts JK; Rao SV; Shaw LK; Gallup DS; Marroquin OC; Patel UD
    Am J Cardiol; 2017 May; 119(9):1344-1351. PubMed ID: 28318510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes mellitus associated with an increased risk of percutaneous coronary intervention long-term adverse outcomes in Taiwan: A nationwide population-based cohort study.
    Chen WW; Chen JY; Li CI; Liu CS; Lin WY; Lin CH; Li TC; Lin CC
    J Diabetes Complications; 2020 Nov; 34(11):107689. PubMed ID: 32843281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes after percutaneous coronary intervention for chronic total occlusion according to baseline renal function.
    Stähli BE; Gebhard C; Gick M; Ferenc M; Mashayekhi K; Buettner HJ; Neumann FJ; Toma A
    Clin Res Cardiol; 2018 Mar; 107(3):259-267. PubMed ID: 29134346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Lipoprotein(a) on Long-term Outcomes in Patients With Diabetes Mellitus Who Underwent Percutaneous Coronary Intervention.
    Konishi H; Miyauchi K; Shitara J; Endo H; Wada H; Doi S; Naito R; Tsuboi S; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H
    Am J Cardiol; 2016 Dec; 118(12):1781-1785. PubMed ID: 27712648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease.
    Tajti P; Karatasakis A; Danek BA; Alaswad K; Karmpaliotis D; Jaffer FA; Choi JW; Yeh RW; Patel M; Mahmud E; Burke MN; Krestyaninov O; Khelimskii D; Toma C; Doing AH; Uretsky B; Koutouzis M; Tsiafoutis I; Wyman RM; Garcia S; Holper E; Xenogiannis I; Rangan BV; Banerjee S; Ungi I; Brilakis ES
    J Invasive Cardiol; 2018 Nov; 30(11):E113-E121. PubMed ID: 30218557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The adverse long-term impact of renal impairment in patients undergoing percutaneous coronary intervention in the drug-eluting stent era.
    Appleby CE; Ivanov J; Lavi S; Mackie K; Horlick EM; Ing D; Overgaard CB; Seidelin PH; von Harsdorf R; Dzavík V
    Circ Cardiovasc Interv; 2009 Aug; 2(4):309-16. PubMed ID: 20031733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic total coronary occlusion treated by percutaneous coronary intervention: long-term outcome in patients with and without diabetes.
    Sanguineti F; Garot P; O'Connor S; Watanabe Y; Spaziano M; Lefèvre T; Hovasse T; Benamer H; Unterseeh T; Chevalier B; Morice MC; Louvard Y
    EuroIntervention; 2017 Feb; 12(15):e1889-e1897. PubMed ID: 27890859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Long-Term Mortality in Patients With Single Coronary Narrowing and Diabetes Mellitus to That of Patients With Multivessel Coronary Narrowing Without Diabetes Mellitus.
    Omair M; Koshy AN; Dinh DT; Brennan AL; Reid CM; Ajani AE; Duffy SJ; Farouque O; Yudi MB; Clark DJ
    Am J Cardiol; 2021 Mar; 142():1-4. PubMed ID: 33285090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z
    Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS).
    Ix JH; Mercado N; Shlipak MG; Lemos PA; Boersma E; Lindeboom W; O'Neill WW; Wijns W; Serruys PW
    Am Heart J; 2005 Mar; 149(3):512-9. PubMed ID: 15864241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.